Navigation Links
Cepheid Reports Third Quarter Revenue of $44.9 Million
Date:10/28/2008

$28.0 $16.4 71%

Clinical Partner 1.6 4.3 -64%

Total Clinical 29.6 20.7 43%

Industrial 4.2 4.4 -4%

Biothreat 8.6 8.9 -3%

Total Product Sales $42.4 $34.0 25%

-- By geography, product sales were, in millions:

Three Months Ended September 30

2008 2007 Change

North America $35.8 $27.6 30%

International 6.6 6.4 2%

Total Product Sales 42.4 34.0 25%

-- During the quarter, Cepheid installed a total of 115 GeneXpert systems

and 879 modules. As of September 30, 2008, a cumulative total of

848 GeneXpert systems and 4,509 modules have been placed worldwide.

-- GAAP gross margin on product sales was 44% and non-GAAP gross margin on

product sales was 46%, which compares to 41% and 43% in the third

quarter of fiscal 2007.

-- Cash, cash equivalents and investments were $45.4 million as of

September 30, 2008, including $21.0 million of auction rate securities.

-- DSO improved to 36 days.

Business Outlook

For the fiscal year ending December 31, 2008, the Company expects:

-- Total revenue to be in the range of $174 to $176 million, of which

product sales are expected to be in the range of $164 to $166 million.

o Xpert MRSA test sales are expected to be in the range of $49 to

$51 million.

-- Net loss for 2008 is expected to be in the range of $22.5 to

$23.5 million, or $(0.39) to $(0.41) per share.

-- On a non-GAAP basis, net loss is expected to be in the range of $6.5 to

$7.5 million, or $(0.11) to $(0.13) per share.

-- Non-
'/>"/>

SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Results of United Kingdom MRSA Surveillance Program Using Cepheid GeneXpert(R) System Demonstrate Benefits of Rapid Testing
2. Cepheid Molecular Diagnostic Test for MRSA and S. aureus Categorized Moderate Complexity by FDA
3. Cepheid Schedules Fiscal 2008 Third Quarter Financial Results Announcement and Webcast
4. Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
5. Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus
6. Cepheid to Webcast Upcoming Financial Presentations
7. Cepheid Introduces GeneXpert(R) Infinity-48 System at 2008 American Association of Clinical Chemistry Meeting
8. Cepheid Reports Second Quarter Revenue of $42.1 Million
9. Cepheid to Webcast Analyst Event
10. Cepheid Schedules Fiscal 2008 Second Quarter Financial Results Announcement and Webcast
11. Noted Molecular Epidemiologist Joins Cepheid to Head Healthcare Associated Infection Consortium Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/18/2010)... ... , ... March 18, 2010 -- Celsense, Inc. announced today its launch of the ... designed to optimize the use of Celsense’ imaging reagents but will be made available ...
(Date:3/17/2010)... took the experimenters three years to believe, University of ... itself can twist ribbons of nanoparticles. , The results ... . , Matter readily bends and twists light. That,s ... glasses. But the opposite interaction has rarely been observed, ...
(Date:3/17/2010)... , ... highlight need for innovation to meet growing global needs sustainably. , ... Washington, DC (PRWEB) March 17, 2010 ... range of benefits modern agriculture has provided to society and emphasized the importance of ...
(Date:3/17/2010)... Dan Maher , Senior Vice President of Product Development of BioMarin, will present a company update at the Barclays Capital Global Healthcare Conference in Miami on ... ... ... ...
Breaking Biology Technology:Novel Imaging Software Released by Celsense Inc. 2Novel Imaging Software Released by Celsense Inc. 3Light twists rigid structures in unexpected nanotech finding 2Light twists rigid structures in unexpected nanotech finding 3Global Food Security Depends on Modern Agriculture 2Global Food Security Depends on Modern Agriculture 3Global Food Security Depends on Modern Agriculture 4BioMarin to Present at the Barclays Capital Global Healthcare Conference 2BioMarin to Present at the Barclays Capital Global Healthcare Conference 3
... Oct. 16 Bristol-Myers Squibb,Company (NYSE: BMY ... Drug,Administration (FDA) has granted approval of IXEMPRA(TM) (ixabepilone) ... or locally,advanced breast cancer in patients whose tumors ... The FDA has also granted,approval of IXEMPRA in ...
... MacroChem,(OTC Bulletin Board: MACM) will participate in the ... New York on October 18 and 19. The ... Sutton Room, throughout each day of,the conference. MacroChem,s ... provide a company overview, including discussion about,MacroChem,s lead ...
... Alimentary Health Ltd.,(Alimentary Health), the development stage ... the use of probiotics in the,treatment of Irritable ... the Alimentary Health probiotic technology marketed as,Bifantis(R), is ... improvement in IBS symptoms. Alimentary Health is ...
Other Biology Technology:FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer 2FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer 3FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer 4FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer 5FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer 6FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer 7MacroChem To Participate in PIPEs Conference October 18th and 19th in New York City 2MacroChem To Participate in PIPEs Conference October 18th and 19th in New York City 3Recent Study Confirms Alimentary Health's Bifantis(R) Demonstrates Efficacy in the Treatment of Irritable Bowel Syndrome 2Recent Study Confirms Alimentary Health's Bifantis(R) Demonstrates Efficacy in the Treatment of Irritable Bowel Syndrome 3Recent Study Confirms Alimentary Health's Bifantis(R) Demonstrates Efficacy in the Treatment of Irritable Bowel Syndrome 4
(Date:3/21/2010)... Calif.A California Institute of Technology (Caltech)-led team of ... that a targeted nanoparticleused as an experimental therapeutic ... into tumors, deliver double-stranded small interfering RNAs (siRNAs), ... a mechanism known as RNA interference (RNAi). Moreover, ... new type of therapy, infused into the bloodstream, ...
(Date:3/21/2010)... FRANCISCO, March 21, 2010 A potential new energy ... junk science is moving closer to acceptance by the ... of one of the largest scientific sessions on the ... the next two days in the Moscone Center during ... (ACS). , "Years ago, many scientists were afraid to ...
(Date:3/18/2010)... , Michael M. Graham, Ph.D., M.D., president, SNM, ... SNM Medical Isotope Task Force, Jeffrey P. Norenberg, Pharm.D., ... SNM Medical Isotope Task Force, , WHEN:,Immediately , ... a two-week period when cancer, heart and brain disease ...
Breaking Biology News(10 mins):Caltech-led team provides proof in humans of RNA interference using targeted nanoparticles 2Caltech-led team provides proof in humans of RNA interference using targeted nanoparticles 3Caltech-led team provides proof in humans of RNA interference using targeted nanoparticles 4'Cold fusion' moves closer to mainstream acceptance 2'Cold fusion' moves closer to mainstream acceptance 3'Cold fusion' moves closer to mainstream acceptance 4Elsevier introduces Aesthetic Plastic Surgery 60149 1Elsevier introduces Aesthetic Plastic Surgery 60149 2Tufts CTSI and Tufts University receive 4 NIH supplemental grant awards 60147 1Tufts CTSI and Tufts University receive 4 NIH supplemental grant awards 60147 2Tufts CTSI and Tufts University receive 4 NIH supplemental grant awards 60147 3World interest in Australian fishery impact test 10539 1World interest in Australian fishery impact test 10539 2
... ring-based reconstruction of an extinct polar forest,s seasonal ... of Lake St. Martin bolide on groundwater quality; ... radar images of volcanic and impact deposits on ... the atmosphere; use of charred plants in modeling ...
... will honor 13 individuals with awards recognizing extraordinary scientific ... ecology, mathematics, oceanography, paleontology, social sciences, and psychology. ... ARCTOWSKI MEDAL a medal and a prize of ... an institution of the recipient,s choosing, awarded every three ...
... Change for the Baltic Sea Basin (BACC), the book published ... possible future climate change in the region, which extends over ... One of the key findings is that air temperatures in ... degrees Celsius from now to 2100. More than 80 scientists ...
Other Biology News:February Geology and GSA Today media highlights 2February Geology and GSA Today media highlights 3February Geology and GSA Today media highlights 4February Geology and GSA Today media highlights 5February Geology and GSA Today media highlights 6February Geology and GSA Today media highlights 7February Geology and GSA Today media highlights 8February Geology and GSA Today media highlights 9February Geology and GSA Today media highlights 10Academy honors 13 for major contributions to science 2Academy honors 13 for major contributions to science 3Academy honors 13 for major contributions to science 4Academy honors 13 for major contributions to science 5Climate change in the Baltic Sea basin -- past, present and future 2Climate change in the Baltic Sea basin -- past, present and future 3
... Peptide microarrays containing peptidomimetics built on ... on-chip synthesis platform. These microarrays are ... Custom Peptide Microarray Service. ... is completely customer specified. Thousands of ...
... These extended-length microarrays are custom designed to ... configurations are available: 8,455 features per array ... 22,575 features per array (1 array/slide). ... probe length - This extended length ...
... Tissue Arrays are intended for laboratory research ... fixed in neutral buffered formalin and embedded ... was performed by certified pathologists. Tissue ... and relocated into a new recipient paraffin ...
... are intended for laboratory research use only. ... neutral buffered formalin and embedded in paraffin. ... by certified pathologists. Tissue cores were ... into a new recipient paraffin block, in ...
Biology Products: